|
Pharmasin 500 WSP
|
500 mg/g
|
V/NRP/08/1714
|
Huvepharma NV, Beļģija
|
QJ01FA90
|
cattle (calf); pigs; turkeys; chickens
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/08/1714-01 |
500 mg/g |
1 |
Polipropilēna pudelīte, 100 g |
-
|
| V/NRP/08/1714-02 |
500 mg/g |
1 |
Polipropilēna pudelīte, 200 g |
-
|
| V/NRP/08/1714-04 |
500 mg/g |
1 |
Maisiņš, 1 kg |
-
|
| V/NRP/08/1714-06 |
500 mg/ml |
1 |
Maisiņš, 25 kg |
-
|
|
|
Pharmasin
|
200 mg/ml
|
V/NRP/08/1713
|
Huvepharma NV, Beļģija
|
QJ01FA90
|
cattle; pigs; sheep; goats
|
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Tylosin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Biovet Joint Stock Company., Bulgārija
|
| Date of authorisation/renewal: |
12-Apr-2013
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] 28072020LI (01-Jul-2025)
|
| Labelling text: |
[PDF] 28072020M (01-Jul-2025)
|
| Summary of product characteristics: |
[DOCX] 28072020ZA (01-Jul-2025)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/08/1713-01 |
200 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
| V/NRP/08/1713-02 |
200 mg/ml |
1 |
Stikla flakons, 100 ml |
-
|
|